World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
7658
World Ranking
4538
National Ranking
17

Su-Hyung Park publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Su-Hyung Park sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 193 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Su-Hyung Park D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Su-Hyung Park sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Su-Hyung Park is affiliated with the Korea Advanced Institute of Science and Technology in South Korea. Their research primarily focuses on medicine, with a strong emphasis on immunology and microbiology. This scientist has contributed extensively to fields such as immunology, oncology, infectious diseases, molecular biology, and neurology.

Their work addresses a range of main topics, including immune cell function and interaction, immunotherapy and immune responses, T-cell and B-cell immunology, cancer immunotherapy and biomarkers, SARS-CoV-2 and COVID-19 research, CAR-T cell therapy research, and COVID-19 clinical research studies.

Su-Hyung Park has published in numerous scientific venues with frequent publications in The Journal of Immunology, Journal of Hepatology, Immune Network, Clinical Cancer Research, and bioRxiv (Cold Spring Harbor Laboratory).

Among their recent papers are:

  • Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 (2020, Science Immunology)
  • PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19 (2020, Immunity)
  • SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells (2021, Nature Communications)
  • Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma (2020, Journal of Hepatology)
  • T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant (2022, Cellular and Molecular Immunology)

They have frequently collaborated with other researchers, including Eui-Cheol Shin, June-Young Koh, Seong Jin Choi, Min-Seok Rha, and Seongju Jeong.

Best Publications

  • Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.

    Jeong Seok Lee;Seongwan Park;Hye Won Jeong;Jin Young Ahn

  • Immune responses and immunopathology in acute and chronic viral hepatitis

    Eui-Cheol Shin;Pil Soo Sung;Pil Soo Sung;Su-Hyung Park

  • Immune Responses to HCV and Other Hepatitis Viruses

    Su-Hyung Park;Barbara Rehermann

  • Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma

    Hyung-Don Kim;Gi-Won Song;Seongyeol Park;Min Kyung Jung

  • VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.

    Chang Gon Kim;Mi Jang;Youngun Kim;Galam Leem

  • YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma

    Min Hwan Kim;Chang Gon Kim;Sang-Kyum Kim;Sang Joon Shin

  • SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.

    Jae Hyung Jung;Min-Seok Rha;Min-Seok Rha;Moa Sa;Hee Kyoung Choi

  • PD-1-Expressing SARS-CoV-2-Specific CD8 + T Cells Are Not Exhausted, but Functional in Patients with COVID-19.

    Min Seok Rha;Hye Won Jeong;Jae Hoon Ko;Seong Jin Choi

  • Predictors of mortality in Middle East respiratory syndrome (MERS)

    Ki Ho Hong;Jae Phil Choi;Seon Hui Hong;Jeewon Lee

  • The first-week proliferative response of peripheral blood PD-1+CD8+ T cells predicts the response to anti-PD-1 therapy in solid tumors

    Kyung Hwan Kim;Jinhyun Cho;Bo Mi Ku;Jiae Koh;Jiae Koh

  • Innate-like Cytotoxic Function of Bystander-Activated CD8+ T Cells Is Associated with Liver Injury in Acute Hepatitis A

    Jihye Kim;Dong Yeop Chang;Hyun Woong Lee;Hoyoung Lee

  • The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity

    Seo Sh;Kim Ks;Park Sh;Suh Ys

  • Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma.

    Chang Gon Kim;Chan Kim;Sang Eun Yoon;Kyung Hwan Kim

  • T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant

    Unknown

  • Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.

    Yang Sh;Lee Cg;Park Sh;Im Sj

  • PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15.

    Kyung Hwan Kim;Kyung Hwan Kim;Hong Kwan Kim;Hyung-Don Kim;Chang Gon Kim

  • Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.

    Jin-Won Youn;Jin-Won Youn;Su-Hyung Park;Dimitri Lavillette;Francois-Loic Cosset

  • BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality

    Unknown

  • 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma

    Hyung Don Kim;Seongyeol Park;Seongju Jeong;Yong Joon Lee

  • Immune-mediated Liver Injury in Hepatitis B Virus Infection

    In Soo Oh;In Soo Oh;Su Hyung Park

  • Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness

    Pil Soo Sung;HyeonJoo Cheon;Chung Hwan Cho;Seon Hui Hong

  • Abnormality in the NK-cell population is prolonged in severe COVID-19 patients.

    Galam Leem;Shinhye Cheon;Hoyoung Lee;Seong Jin Choi

  • Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C

    Eui–Cheol Shin;Su–Hyung Park;Mary DeMino;Michelina Nascimbeni

  • Successful Vaccination Induces Multifunctional Memory T-Cell Precursors Associated With Early Control of Hepatitis C Virus

    Su–Hyung Park;Eui–Cheol Shin;Eui–Cheol Shin;Stefania Capone;Laura Caggiari

Frequent Co-Authors

Eui-Cheol Shin
Eui-Cheol Shin Korea Advanced Institute of Science and Technology
Young Chul Sung
Young Chul Sung Pohang University of Science and Technology
Barbara Rehermann
Barbara Rehermann National Institute of Diabetes and Digestive and Kidney Diseases
Young Seok Ju
Young Seok Ju Korea Advanced Institute of Science and Technology
Myung-Ju Ahn
Myung-Ju Ahn Sungkyunkwan University
Young Ki Choi
Young Ki Choi Institute for Basic Science
Charles M. Rice
Charles M. Rice Rockefeller University
Kwang Hyub Han
Kwang Hyub Han Yonsei University
Sang-Nae Cho
Sang-Nae Cho Yonsei University
Theo Heller
Theo Heller National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can broaden career prospects. Many choose to pursue nursing paths, which often align with immunological research and patient care. One effective option is transitioning from a Family Nurse Practitioner (FNP) to Acute Care Nurse Practitioner (ACNP) role, a move that demands advanced skills and specialized knowledge. Learn more about this step through fnp to acnp resources.

Accelerated programs offer a fast track for those looking to gain qualifications efficiently. There are several highly regarded options for those seeking an expedited nursing education, including accelerated nurse practitioner programs. These programs combine rigorous coursework with flexible online formats, making advanced nursing degrees more accessible.

For individuals without a nursing background, starting with a Bachelor of Science in Nursing (BSN) is a common route. The best online BSN programs for non nurses facilitate this transition and prepare students for further specialization in areas tied to immunology and healthcare. Explore excellent options in best online bsn programs for non nurses.

Additionally, if you’re eager to enter the field quickly, accelerated BSN programs designed for non nurses provide an ideal pathway. These programs focus on delivering essential clinical and theoretical nursing education in a condensed timeframe. Check out some of the accelerated bsn programs for non nurses to find one that fits your goals.

Best Scientists Citing Su-Hyung Park

Trending Scientists

Recently Published Articles